Médicos Brasil

Seizures

Significado para o sintoma Seizures

Seizures são convulsões que podem ser causadas por um número de condições médicas, incluindo doenças do sistema nervoso central, traumas, infecções, intoxicação por drogas ou álcool, ou mesmo condições genéticas. Os sintomas de uma crise epiléptica variam de pessoa para pessoa, mas geralmente envolvem perda de consciência, movimentos musculares incontroláveis, espasmos musculares ou contorções, e podem incluir tonturas, tremores, desmaios, confusão, atividade motora anormal e alterações de comportamento. Seizures podem durar de alguns segundos a vários minutos, e os sintomas podem variar de leve a grave. Alguns tipos de convulsões não exigem tratamento, mas outros podem exigir medicamentos ou outros tratamentos para controlar os sintomas. É importante procurar atenção médica imediatamente se você ou alguém que você conhece tiver sintomas de uma convulsão.

Tudo sobre: Seizures

Medicamento • Sistema Nervoso Central • Medley Farmacêutica Ltda.

Alzepinol

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Torrent do Brasil Ltda.

Oleptal

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Torrent do Brasil Ltda.

Oxcarbazepina Torrent

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Sanofi Medley Farmacêutica Ltda.

Oxcarbazepina Sanofi

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • União Química Farmacêutica Nacional S.A.

Oxcarbazepina Comprimido União Química

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Ranbaxy Farmacêutica Ltda

Selzic

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Ranbaxy Farmacêutica Ltda

Oxcarbazepina Ranbaxy

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • União Química Farmacêutica Nacional S.A.

Oxcarb

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • União Química Farmacêutica Nacional S.A.

Oxcarbazepina Suspensão Oral União Química

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Novartis Biociências S.A.

Trileptal

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Zydus Nikkho Farmacêutica Ltda.

Zyoxipina

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Desconhecido

Oxcarbazepina

Safety and efficacy of 1200 mg/day of oxcarbazepine monotherapy versus placebo in patients with recent-onset partial seizures. Protocol 025. Novartis Pharmaceuticals Corp.... A multicenter, randomised, double-blind, placebo-controlled, parallel, add-on trial of oxcarbazepine in children with inadequately-controlled partial seizures. Protocol 011.... Efficacy and clinical utility of Oxcarbazepine in patients with generalised tonic-clonic seizures: A meta-analysis. Novartis Pharma AG.

Medicamento • Sistema Nervoso Central • Eurofarma Laboratórios S.A.

Antara

b.i.d.), used as monotherapy for up to a maximum of 121 weeks in subjects (≥ 16 years) newly or recently diagnosed as suffering from epilepsy, and experiencing partial or generalized tonic-clonic seizures... Clinical study report N051: Evaluation of the efficacy and tolerability of ucb L059 (500 and 1000 mg b.i.d., tablets) add-on treatment in refractory epileptic patients with partial onset seizures : a 32... improved seizure control under add-on treatment.

Medicamento • Sistema Nervoso Central • Zodiac Produtos Farmacêuticos S.A.

Levetiracetam Zodiac

b.i.d.), used as monotherapy for up to a maximum of 121 weeks in subjects (≥ 16 years) newly or recently diagnosed as suffering from epilepsy, and experiencing partial or generalized tonic-clonic seizures... Clinical study report N051: Evaluation of the efficacy and tolerability of ucb L059 (500 and 1000 mg b.i.d., tablets) add-on treatment in refractory epileptic patients with partial onset seizures : a 32... improved seizure control under add-on treatment.

Medicamento • Sistema Nervoso Central • Eurofarma Laboratórios S.A.

Levetiracetam Eurofarma

b.i.d.), used as monotherapy for up to a maximum of 121 weeks in subjects (≥ 16 years) newly or recently diagnosed as suffering from epilepsy, and experiencing partial or generalized tonic-clonic seizures... Clinical study report N051: Evaluation of the efficacy and tolerability of ucb L059 (500 and 1000 mg b.i.d., tablets) add-on treatment in refractory epileptic patients with partial onset seizures : a 32... improved seizure control under add-on treatment.

Não encontrou o que estava buscando?

medicosbrasil.com © 2024